Physician profile
Andrew S Greenberg
NPI 1811211980
$85,897.94
in general payments reported to CMS, 2019-2025
25 companies · $21K in 2025
The $21K reported for 2025 was more than what 96% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52K · 2020: $10K · 2021: $594 · 2022: $1,104 · 2023: $810 · 2024: $469 · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Food and Beverage: $1,273 · Travel and Lodging: $293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,500.00 |
| Food and Beverage | $1,273.02 |
| Travel and Lodging | $293.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medartis INC. | $45,557.70 | 2019-2025 | Aptus |
| Arthrex, INC. | $37,425.89 | 2019-2025 | |
| Bioventus LLC | $448.07 | 2019-2025 | Durolane, Durolane |
| Acumed LLC | $338.82 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $332.23 | 2023-2024 | Comprehensive Shoulder System, Comprehensive, Comprehensive |
| Stryker Corporation | $304.22 | 2019-2023 | Gamma |
| Endo Pharmaceuticals INC. | $246.31 | 2019-2024 | Xiaflex |
| Hitachi Healthcare Americas Corp. | $175.69 | 2019 | |
| Djo, LLC | $161.19 | 2022-2024 | Cmf |
| Linvatec Corporation | $160.94 | 2022-2023 | Biobrace 23mm |
| Depuy Synthes Sales INC. | $141.41 | 2019-2024 | Healix Knotless Peek |
| Ferring Pharmaceuticals INC. | $136.81 | 2021-2023 | Euflexxa |
| Abbvie INC. | $95.04 | 2022 | |
| Arcuro Medical INC | $74.69 | 2024 | Superball |
| Medtronic, INC. | $58.33 | 2023 | V-Loc 180 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $48.98 | 2019 | |
| Endo USA, INC. | $47.10 | 2025 | Xiaflex |
| Janssen Biotech, INC. | $43.90 | 2025 | Tremfya |
| Si-Bone, INC. | $21.03 | 2019 | |
| Biomarin Pharmaceutical INC. | $16.77 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $15.53 | 2023 | Seglentis |
| Kci USA, INC. | $12.25 | 2022 | |
| Sanofi-Aventis U.S. LLC | $12.24 | 2019 | |
| Nevro Corp. | $11.59 | 2020 | |
| Convatec INC. | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Greenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.